February 19, 2018 / 7:24 AM / 6 months ago

BRIEF-AstraZeneca ‍Says US FDA Approves Imfinzi For Unresectable Stage III Non-Small Cell Lung Cancer​

Feb 19 (Reuters) - AstraZeneca Plc:

* ‍US FDA APPROVES IMFINZI FOR UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER​

* ‍ASTRAZENECA'S IMFINZI APPROVED FOR STAGE III NSCLC​

* ‍IMFINZI IS ONLY IMMUNOTHERAPY APPROVED FOR PATIENTS WITH UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below